Mesa Laboratories, Inc. (MLAB)
NASDAQ: MLAB · Real-Time Price · USD
125.16
+1.85 (1.50%)
At close: Oct 20, 2026, 4:00 PM EDT
125.54
+0.38 (0.30%)
Pre-market: Oct 21, 2026, 8:30 AM EDT
Mesa Laboratories Financials Overview
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 249.73 | 249.13 | 240.98 | 216.19 | 219.08 | 184.34 |
Revenue Growth | 3.04% | 3.38% | 11.47% | -1.32% | 18.85% | 37.63% |
Gross Profit Gross Profit Growth | 160.34 | 158.27 | 152.1 | 134.48 | 133.69 | 109.09 |
Operating Income Operating Income Growth | 22.48 | 18.51 | 17.57 | 3.69 | 3.32 | 4.7 |
Net Income Net Income Growth | 4.8 | 6.71 | -1.97 | -254.25 | 0.93 | 1.87 |
Earnings Per Share EPS Growth | 0.86 | 1.21 | -0.36 | -47.20 | 0.17 | 0.35 |
EPS Growth | - | - | - | - | -51.43% | -45.31% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Sterilization and Disinfection Control Sterilization and Disinfection Control Growth | 100.66 | 101.57 | 93.42 | 75.12 | 64.61 | 59.04 |
Biopharmaceutical Development Biopharmaceutical Development Growth | 49.2 | 48.63 | 48.73 | 40.71 | 47.37 | 45.58 |
Calibration Solutions Calibration Solutions Growth | 54.49 | 53.55 | 51.75 | 47.76 | 44.81 | 46.87 |
Clinical Genomics Clinical Genomics Growth | 45.38 | 45.39 | 47.08 | 52.59 | 62.3 | 32.84 |
Total Total Growth | 249.73 | 249.13 | 240.98 | 216.19 | 219.08 | 184.34 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 32.24 | 28.57 | 29.07 | 30.11 | 32.91 | 49.35 |
Total Debt Total Debt Growth | 161.35 | 168.83 | 193.85 | 231.3 | 191.89 | 228.57 |
Net Cash (Debt) Net Cash Growth | -129.11 | -140.26 | -164.78 | -201.19 | -158.98 | -179.22 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -22.99 | -25.20 | -30.40 | -37.35 | -29.66 | -33.59 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 55.67 | 42.83 | 46.81 | 44.13 | 27.98 | 39.22 |
Capital Expenditures CapEx Growth | -2.8 | -3.25 | -4.25 | -2.57 | -4.54 | -4.43 |
Free Cash Flow Free Cash Flow Growth | 52.87 | 39.58 | 42.56 | 41.57 | 23.44 | 34.79 |
Free Cash Flow Growth | 57.40% | -7.00% | 2.39% | 77.34% | -32.63% | -0.83% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 64.21% | 63.53% | 63.12% | 62.20% | 61.02% | 59.18% |
Operating Margin | 9.00% | 7.43% | 7.29% | 1.70% | 1.52% | 2.55% |
Pretax Margin | 3.75% | 4.82% | 2.47% | -127.50% | -0.18% | 1.94% |
Profit Margin | 1.92% | 2.69% | -0.82% | -117.61% | 0.43% | 1.01% |
FCF Margin | 21.17% | 15.89% | 17.66% | 19.23% | 10.70% | 18.87% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.640 | 0.640 | 0.640 | 0.640 | 0.640 | 0.640 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 0.51% | 0.72% | 0.54% | 0.58% | 0.37% | 0.25% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 145.39 | 72.78 | - | - | 1004.45 | 714.64 |
Forward PE | 56.51 | 63.76 | 16.50 | 17.53 | 27.40 | 39.18 |
P/FCF Ratio | 13.25 | 12.34 | 15.15 | 14.24 | 39.85 | 38.43 |
PS Ratio | 2.80 | 1.96 | 2.68 | 2.74 | 4.26 | 7.25 |